Treatment with the amylin analog pramlintide has been shown to reduce weight in obese patients, according to researchers.

A simple imaging technique has revealed fat buildup in the hearts of pre-diabetic people long before symptoms of heart disease or diabetes appear.

If the benefits seen in the study were applied to just half the population with diabetes worldwide, more than a million deaths would be avoided over five years.

Diabetics have twice the risk of developing hearing loss as are nondiabetics.

Accumulating scientific evidence indicates that light to moderate drinking done on a daily basis may significantly reduce the risks of coronary heart disease (CHD) and all-cause mortality.

Among healthy middle-aged and older women, Hemoglobin A1c is an independent predictor of type 2 diabetes, but not cardiovascular disease.

Forty-four percent of patients treated with metformin and sitagliptin were able to achieve A1c’s below 6.5%

Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported.

One reason for this is thought to be the chronic inflammation characterized by macrophage infiltration into adipose tissue that accompanies obesity, because it has been linked to the development of insulin resistance (which in turn often leads to type 2 diabetes).

Thiazolidinediones Receive Black Box For Heart Failure: Careful monitoring of patients advised.